MedChemComm

From Wikipedia, the free encyclopedia
Jump to: navigation, search
MedChemComm  
CoverIssueMedChemComm.jpg
Abbreviated title (ISO 4)
Med. Chem. Commun.
Discipline Chemistry, medicine
Language English
Edited by Anthony Wood, Greg Verdine
Publication details
Publisher
Royal Society of Chemistry (United Kingdom)
Publication history
2010-present
Frequency Monthly
Hybrid
2.626
Indexing
ISSN 2040-2503 (print)
2040-2511 (web)
LCCN 2011243017
OCLC no. 663378788
Links

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. It is published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it is the official journal. Authors can elect to have accepted articles published as open access.[1] According to the Journal Citation Reports, the journal has a 2013 impact factor of 2.626, ranking it 25th out of 59 journals in the category "Chemistry, Medicinal"[2] and 153 out of 290 journals in the category "Biochemistry & Molecular Biology".[3]

The editors-in-chief are Anthony Wood (Pfizer, USA) and Greg Verdine (Harvard University).[4]

Article types[edit]

MedChemComm publishes Concise Articles (original scientific work, 3-7 pages in length) and Reviews (critical analyses of specialist areas).[4]

References[edit]

  1. ^ "RSC Open Science". Royal Society of Chemistry. 2006-10-01. Retrieved 2012-07-07. 
  2. ^ "Journals Ranked by Impact: Chemistry, Medicinal". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014.  (subscription required)
  3. ^ "Journals Ranked by Impact: Biochemistry & Molecular Biology". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014.  (subscription required)
  4. ^ a b "About MedChemComm". Royal Society of Chemistry. Retrieved 2012-07-07. 

External links[edit]